POLYRIZON
Polyrizon is a domain name services firm expertise in domain consulting and boutique domain brokerage services.
POLYRIZON
Social Links:
Industry:
Biotechnology
Address:
Ra'anana, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.polyrizon-biotech.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API WordPress Google Maps LetsEncrypt SSL By Default Font Awesome
Similar Organizations
albero
albero is a company that expertise in domain registration, web construction and CMS services.
Domain Cocoon
Domain Cocoon helps to protect and grow domain names and provides custom registrar solutions, consultation and management services.
Yash Infosolutions
Yash Infosolutions is an IT company that provides domain registration, web design, security management, consultation, and cloud services.
Current Employees Featured
Official Site Inspections
http://www.polyrizon-biotech.com
- Host name: 699050.cloudwaysapps.com
- IP address: 46.101.45.46
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Polyrizon"
PLRZ - Overview
Polyrizon Ltd. Company Overview We are a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, …See details»
Polyrizon Expands Drug Delivery Innovation with Preclinical …
4 days ago Raanana, Israel, March 25, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in …See details»
Polyrizon Expands Drug Delivery Innovation with Preclinical
4 days ago Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin …See details»
PLRZ - Press Releases Detail - investor.polyrizon-biotech.com
5 days ago According to the World Health Organization (WHO), epilepsy is a neurological condition affecting about 50 million people worldwide. Many existing therapies fail to provide …See details»
Polyrizon - Crunchbase Company Profile & Funding
4,031 Number of Organizations • $19.1B Total Funding Amount • 2,412 Number of Investors Track Biotechnology Public Companies With Fewer Than 100 EmployeesSee details»
Polyrizon Company Profile - Office Locations, Competitors, …
Oct 29, 2024 Polyrizon has 1 employees at their 1 location. See insights on Polyrizon including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. ...See details»
Polyrizon Enters into GMP Manufacturing Agreement for CTM
Dec 3, 2024 Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin …See details»
Polyrizon Announces Closing of $4.2 Million Initial Public
Raanana, Israel, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (the "Company" or "PLRZ"), a development stage biotech company specializing in the development of innovative …See details»
Polyrizon’s Moving Forward with Expected 2025 Clinical Trial
Raanana, Israel, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of …See details»
Polyrizon Signs Non– Binding LOI to Expand its Innovative
Mar 14, 2025 Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, …See details»
Polyrizon Expands Drug Delivery Innovation with Preclinical …
5 days ago Raanana, Israel, March 25, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in …See details»
PLRZ - Press Releases Detail - investor.polyrizon-biotech.com
Dec 18, 2024 Polyrizon refers to its additional technology, which is in an earlier stage of pre-clinical development, that is focused on nasal delivery of active pharmaceutical ingredients, or …See details»
Polyrizon Signs Non– Binding LOI to Expand its Innovative …
Mar 14, 2025 Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, …See details»
Polyrizon's Moving Forward with Expected 2025 Clinical Trial
Dec 18, 2024 Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, …See details»
Polyrizon Structures Clinical Strategy for its Allergy ... - BioSpace
2 days ago Studies to assess efficacy, safety, user experience, and nasal residence time as Company prepares for regulatory path forward. Raanana, Israel, March 27, 2025 (GLOBE …See details»
Polyrizon Expands Drug Delivery Innovation with Preclinical …
4 days ago Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin …See details»
Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead …
3 days ago Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin …See details»
Polyrizon begins preclinical studies for seizure treatment
5 days ago RAANANA, Israel - Polyrizon Ltd. (NASDAQ:PLRZ), a biotech firm in the development stage, has initiated preclinical studies for a new intranasal delivery system for …See details»
PLRZ Press Release: Polyrizon Expands Drug Delivery Innovation wi...
5 days ago According to the World Health Organization (WHO), epilepsy is a neurological condition affecting about 50 million people worldwide. Many existing therapies fail to provide …See details»
Polyrizon - CAPTURE & CONTAIN
The Capture and Contain Platform (C&C™) is based on natural 3-D polymeric network tailored to optimally adhere to the nasal mucosal surface. The polymeric network creates a physical …See details»